Coverage Validation

What's possible

Build government systems on the law

Check a workflow Reconcile primary sources

Ground AI models in citable law

Ask about benefits and taxes

Power products on rules you don't rebuild

Simulate policy on real rules

Explore benefits cliffs Simulate household impacts

Axiom Citations Slides

Team Get started

loading…

Computable law for all.

Open, machine-readable encodings of the world's rules — starting with tax and benefit policy.

Product

Axiom platform
Demos
Coverage
Validation
Citations
Documentation

Foundation

About
Team
Blog
Privacy

Connect

Contact
Get updates
hello@axiom.org

© 2026 Axiom Foundation · Doing the public-interest work

Open infrastructure for encoded law

us/regulation/42/447/subpart-I — Subpart I - Payment for Drugs · Axiom

Axiom
US Federal
Regulations
Title 42
Part 447

Subpart I - Payment for Drugs

16 sections

Basis and purpose
Definitions
Determination of average manufacturer price
Determination of best price
Authorized generic drugs
Identification of inhalation, infusion, instilled, implanted, or injectable drugs (5i drugs)
Exclusion from best price of certain sales at a nominal price
Medicaid drug rebates (MDR)
Requirement and penalties for manufacturers
Requirements for States
Drugs: Aggregate upper limits of payment
Upper limits for multiple source drugs
Upper limits for drugs furnished as part of services
State plan requirements, findings, and assurances
Federal Financial Participation (FFP): Conditions relating to physician-administered drugs
Optional coverage of investigational drugs and other drugs not subject to rebate